JPS63304991A - Production of (r)-gamma-substituted-beta-hydroxybutyric ester - Google Patents

Production of (r)-gamma-substituted-beta-hydroxybutyric ester

Info

Publication number
JPS63304991A
JPS63304991A JP62142916A JP14291687A JPS63304991A JP S63304991 A JPS63304991 A JP S63304991A JP 62142916 A JP62142916 A JP 62142916A JP 14291687 A JP14291687 A JP 14291687A JP S63304991 A JPS63304991 A JP S63304991A
Authority
JP
Japan
Prior art keywords
substituted
gamma
nadph
ester
optimum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62142916A
Other languages
Japanese (ja)
Other versions
JP2566960B2 (en
Inventor
Hideaki Yamada
秀明 山田
Akira Shimizu
昌 清水
Teruzo Miyoshi
照三 三好
Masaaki Kato
正明 加藤
Tadashi Morikawa
忠志 守川
Masamichi Hashimoto
正道 橋本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Denka Co Ltd
Original Assignee
Denki Kagaku Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denki Kagaku Kogyo KK filed Critical Denki Kagaku Kogyo KK
Priority to JP62142916A priority Critical patent/JP2566960B2/en
Publication of JPS63304991A publication Critical patent/JPS63304991A/en
Application granted granted Critical
Publication of JP2566960B2 publication Critical patent/JP2566960B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PURPOSE:To efficiently produce the titled compound, by treating a gamma-substituted acetoacetic ester with an NADPH-dependent reductase of reduction type derived from a fungus belonging to the genus Sporobolomyces. CONSTITUTION:Sporobolomyces salmonicolor is cultivated in a medium to produce an NADPH-dependent reductase of reduction type having 32,000 (Sephadex) mol.wt. and the following physical and chemical properties. Action: catalyzing a reaction to form an alcohol from an aldehyde or a ketone. Optimum pH and stable pH: optimum pH is approximately 7 and stable range is pH 6-10. Optimum temperature and stable temperature: optimum temperature is approximately 60 deg.C and stable range is 40-60 deg.C. Inhibitor: being inhibited with Mg<3+> or Fe<3+>. A reaction solution containing <=10% gamma-substituted acetoacetic ester is treated with the reductase in the presence of NADPH at 20-40 deg.C at pH 6-12 to produce (R)-gamma-substituted-beta-hydroxybutyric ester.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 近年、光学活性オキジ酸誘導体類は、医薬、農薬合成中
間体として、その有用性が増しつつあムこれら光学活性
オΦシ酸誘導体類の内、(R)−r−置換−β−ハイド
ロギク酪酸エステルの製造法につき穐々検討した結果、
本発明者らにより見出された新規還元酵素を用いれば効
果的にγ−憶換アセト酢酸エステルから製造出来ること
全見出し本発明?完成した。
[Detailed Description of the Invention] [Field of Industrial Application] In recent years, optically active oxyacid derivatives have become increasingly useful as intermediates for the synthesis of pharmaceuticals and agricultural chemicals. As a result of extensive investigation into the manufacturing method of (R)-r-substituted-β-hydroxybutyric acid ester,
The novel reductase discovered by the present inventors can be used to effectively produce γ-recombinant acetoacetate.The entire heading of the present invention? completed.

〔従来の技術〕[Conventional technology]

従来よシ、γ−置換アセト酢酸エステルに作用j、(u
)−r−置換−β−・・イドロ會シ酢酸エステルを生成
するには、微生物起源としては酵母由来のL−β−ハイ
ドロ印ジアシルCOAデヒドロデナーゼ(EC1,1,
1,35〕(特開昭59−118093号公報)及びサ
ーモアネアロビウムデロキイ(Tharmoanasr
obium broalcil )由来のアルコールデ
しドロデナーゼ(EC1,1,1,2’+(J、A、C
,S、、1985.107.4028)が知られている
Conventionally, it acts on γ-substituted acetoacetate,
)-r-substituted-β-... To produce hydrocyanacetic acid ester, yeast-derived L-β-hydroindicyl COA dehydrodenase (EC1, 1,
1,35] (Japanese Unexamined Patent Publication No. 118093/1983) and Thermoanaerobium derokii (Thermoanasr.
Alcohol dehydrogenase (EC1,1,1,2'+(J,A,C
, S., 1985.107.4028) is known.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

しかしながら、的者は反応性・温度安定性の点で、又後
者は嫌気培養である等改善の余地があシ、これら金側用
した(R)−r−置換−β−ノーイV口やシ酪酸エステ
ルの製造法は実用的とは鴇い難かった。
However, there is room for improvement in terms of reactivity and temperature stability, and the latter requires anaerobic culture. The method for producing butyric acid ester was difficult to find practical.

〔問題点?!−β−する九めの手段〕〔problem? ! -β- Ninth means]

本発明は、γ−置換アセト酢酸エステルにスポロボロマ
イセス属由来の還元型ニコチンアミド・アデニン・ジヌ
クレオチド・リン酸(以下NAr)PHと言つ)依存性
還元酵素を作用させる事tIFI徴とする(R)−γ−
置換−β−ハイドロキシ絡酸エステルの製造法である。
The present invention provides a method for treating γ-substituted acetoacetic esters with a reduced nicotinamide adenine dinucleotide phosphate (hereinafter referred to as NAr)-dependent reductase derived from the genus Sporobolomyces, thereby reducing the tIFI symptoms. (R)-γ-
This is a method for producing a substituted -β-hydroxy fluoric acid ester.

本発明で使用する上記還元酵素は、スポロボロマイセス
・サルモニカラ−(SPorobolomyaesga
lmonicolor ) IFO1038から還元能
力を有する酵素r抽出精製したものである。この酵素は
公知酵素に比し、実用上優れた諸物性を有する新規還元
酵素であることが明らかなので別途提案した。
The above-mentioned reductase used in the present invention is derived from Sporobolomyces salmonicolar (SPorobolomyaeesga).
lmonicolor) It is extracted and purified from IFO1038 using an enzyme having reducing ability. This enzyme was proposed separately because it is clear that it is a new reductase that has various physical properties that are practically superior to known enzymes.

次に、本発明で使用する酵素の調整とその諸物性につき
具体的に記す。
Next, the preparation of the enzyme used in the present invention and its physical properties will be specifically described.

グルコース5憾、コーンステイーfリカー51からなる
培地< PHs、o )で生育せしめたスポロボロマイ
セス サルモニカラーτFo1038に、遠心分離によ
り集薄し、リン隈緩衝液で洗浄後、ダイノミル(シンマ
ルエンタープライズ社製)で細胞を破砕し、酵素を抽出
する。遠心分離後、得られた無細胞抽出液?硫安分画し
、60〜80%、飽和画分を集める。1晩透析後、DE
AE−セファセル(ファーマシア社製)カラムに吸着さ
せてから塩化ナトリウム0から0.6Mによる直線グラ
ジェント溶出を行い活性画分を集める。更にデル濾過ク
ロマト処理(ファーマシア社製セファデックスG−10
0)によシ、活性画分を集め、上記と同様に再びデル濾
過クロマト処理を行い精製酵素液標品を得る。これは、
電気泳動的に均一である。
Sporobolomyces salmonicolor τFo1038 grown in a medium consisting of 5% glucose and 51% cornstarch liquor was collected by centrifugation, washed with Linkuma buffer, and then incubated with Dynomil (manufactured by Shinmaru Enterprises). ) to crush the cells and extract the enzyme. Cell-free extract obtained after centrifugation? Fractionate ammonium sulfate and collect 60-80% saturated fractions. After overnight dialysis, DE
After adsorption onto an AE-Sephacel (manufactured by Pharmacia) column, linear gradient elution with 0 to 0.6 M sodium chloride is performed to collect active fractions. Furthermore, Dell filtration chromatography treatment (Sephadex G-10 manufactured by Pharmacia)
0) Collect the active fractions and perform Delfiltration chromatography again in the same manner as above to obtain a purified enzyme solution sample. this is,
Electrophoretically homogeneous.

なお、この酵素の結晶化品は得られていない。Note that a crystallized product of this enzyme has not been obtained.

次に、本発明で使用する酵素の理化学的性質?記す。Next, what are the physical and chemical properties of the enzyme used in the present invention? write down

■ 作用:補酵素NADPHの存在下、1モルのアルデ
ヒド又はケトン類を基質とし、1モ ルのアルコール類?生成する。
■ Action: In the presence of coenzyme NADPH, 1 mol of aldehyde or ketone as substrate, 1 mol of alcohol? generate.

■ 基質特異性二下記各基質に対する活性を、γ−クロ
ルアセト酢酸エチルを基準とし て表わす。尚、活性測定法に次による。
(2) Substrate specificity 2 The activity for each substrate below is expressed using ethyl γ-chloroacetoacetate as a standard. The activity measurement method is as follows.

基質600nモルとNADPH192nモル?0.−の
酵素液(0,1M 17ン酸緩衝液、p)I 7.0 
)に添加し、67℃、340nmの吸光度変化?測定し
求める。
600 nmol of substrate and 192 nmol of NADPH? 0. - Enzyme solution (0.1M 17-phosphate buffer, p) I 7.0
), change in absorbance at 67℃ and 340nm? Measure and find.

(1)  ケトン類に対する活性 第1表 (4)補酵素 ・NADPHに対し活性有り。(1) Activity against ketones Table 1 (4) Coenzyme ・Active against NADPH.

・NADHにコチンアミドアデニンジヌクレオ÷−)に
対し作用しない。
- Does not act on cotinamide adenine dinucleo ÷ -) on NADH.

(Ill)  アルコール類 第2表のアルコール類に対して実質的に活性は認められ
ない。
(Ill) Alcohols Substantially no activity is observed against the alcohols listed in Table 2.

第2表 ■ 至適−及び安定−範囲 至適−は7近辺にある、また、Pl″16〜1Dで55
℃、10分間処理した場合でも80チ以上の活性が残存
する。
Table 2 ■ Optimum and stable range optimal is around 7, and Pl″16 to 1D is 55
Even when treated at ℃ for 10 minutes, more than 80% activity remains.

■ 至適温度及び安定温度範囲 至適温度は60℃付近にある。また、FJ−17,0,
10分間処理では40℃で100160℃で70チの活
性が残存する。
■ Optimal temperature and stable temperature range The optimal temperature is around 60°C. Also, FJ-17,0,
When treated for 10 minutes, an activity of 100 at 40°C and 70 at 160°C remains.

■ 金属イオン及び各種薬剤の影響 ■ 光学選択性 r−置換アセト酢酸エステルの還元反応生成物も(R)
一体で光学純度は97%as以上である。
■ Effects of metal ions and various drugs ■ Reduction reaction products of optically selective r-substituted acetoacetic esters (R)
As a whole, the optical purity is 97% or more.

第4表 生成物の光学純度は、(+)−α−メト=?シーα−ト
リフルオロメチルフェニル酢[(MTPA )とのエス
テルを合成し、ジアステレオマー化合物とし次後、高速
液体クロマトグラフィ(HPLC)にエリ分離定量する
Optical purity of Table 4 product is (+)-α-meth=? An ester with C-α-trifluoromethylphenylacetic acid [(MTPA) is synthesized to form a diastereomeric compound, and then separated and quantified using high performance liquid chromatography (HPLC).

)(PLO条件 カラA : parttst15 (
ワットブン社製) (4,6φX 250 sx )移
動相:へ午サン:テトラクロロフ ラン:メタノール=600: 100:1 速 度:2.0d/分 検出(吸光度波−長) : 217 nm■ 有機溶媒
に対する安定性 第5表の有機溶媒を含むpH7,0のリン酸緩衝液中で
28℃、24時間処理した場合でも80%以上の活性を
保有している。
) (PLO condition empty A: partstst15 (
(manufactured by Watbun) (4,6φX 250sx) Mobile phase: Sansan: Tetrachlorofuran: Methanol = 600: 100:1 Speed: 2.0 d/min Detection (absorbance wavelength): 217 nm Organic solvent Stability against: Even when treated in a phosphate buffer solution of pH 7.0 containing the organic solvent shown in Table 5 at 28°C for 24 hours, it retains an activity of 80% or more.

第5表 ■ 等電点 …4.7 ■ 分子量 52.000 (セファデックスG−100のデル濾過
法) 36.500 CSD8 (ソジウムドデシルサルフエ
ート)1気泳動法〕 本発明で使用する新規還元酵素を生産するには、常法に
従って、当該菌r培養することができる。
Table 5 ■ Isoelectric point...4.7 ■ Molecular weight 52.000 (Sephadex G-100 Del filtration method) 36.500 CSD8 (Sodium dodecyl sulfate) 1 gas phoresis method] New reduction used in the present invention In order to produce the enzyme, the bacteria can be cultured according to a conventional method.

培養に用いられる培地は微生物の生育に必要な炭素源、
窒素源、無機物質等を含む通常の培地である。更に、ビ
タミン、アミノ酸等の有機微量栄讐゛素を添加すると望
ましい結果が得られる場合が多い。
The medium used for culture contains carbon sources necessary for the growth of microorganisms,
This is a normal medium containing a nitrogen source, inorganic substances, etc. Additionally, desirable results are often obtained by adding organic trace nutrients such as vitamins and amino acids.

培i!は好気的条件下、pH5〜8、温度10〜40’
Cの任意の範囲に制御しつつ1〜10日間行う。
Cultivate! under aerobic conditions, pH 5-8, temperature 10-40'
The test is carried out for 1 to 10 days while controlling C within an arbitrary range.

当該菌を培養して電気泳動的に均一なアルデヒV還元酵
素を得るには、通常の硫安分画、アフイニテイクロマト
グラフイ、イオン交換クロマトグラフィ、デルろ過クロ
マトグラフィ等が用いられる。
In order to obtain electrophoretically uniform aldehye V reductase by culturing the bacteria, conventional ammonium sulfate fractionation, affinity chromatography, ion exchange chromatography, Delfiltration chromatography, etc. are used.

γ−fil換アセト酢酸エステルからの(R)−γ−置
置換−β−ハイドロフシ酪酸エステル合成にあたって使
用する酵素の形態は、精製、半精製、酵素含有菌体、菌
体処理物及びこれらの固定化物などいづれも使用出来る
。使用菌株であるスボロボロマイセスサルモニカラ−U
FO105Bには(S)−γ−−換−β−ハイげロキシ
酪酸エステルを生成する酵素も含有されているため予め
除去しておく必要がある。
The forms of the enzyme used in the synthesis of (R)-γ-substituted-β-hydrofushibutyric acid ester from γ-fil-substituted acetoacetate include purified, semi-purified, enzyme-containing bacterial cells, processed bacterial cells, and their immobilization. Any chemical can be used. The strain used is Sboroboromyces salmonicara-U.
Since FO105B also contains an enzyme that generates (S)-γ-converted-β-hyperoxybutyric acid ester, it must be removed in advance.

基質としてのγ−g1−アセト酢酸エステルの使用濃度
は201!量チ程度迄可能であるが、濃度上昇につれ反
応が阻害される頌向にあるため、10重量憾以下η為又
は低濃度分添又は連続添加が望ましい。
The concentration of γ-g1-acetoacetate used as a substrate was 201! Although it is possible to add up to 10% by weight, since the reaction tends to be inhibited as the concentration increases, it is preferable to add less than 10% by weight, or to add in portions or continuously at low concentrations.

γ−−換アセト酢酸エステルのγ位置換基としては、ク
ロル、クロル、フルオロ、アシド基などが好ましく、エ
ステル基としては炭素数1〜10のアルキル基が好まし
い。
The γ-position substituent of the γ-substituted acetoacetic ester is preferably chloro, chloro, fluoro, acid group, etc., and the ester group is preferably an alkyl group having 1 to 10 carbon atoms.

補酵素として、NAJ)PHk必須とするため、反応系
にNADPH’(必要量予め添加するか、又はNADP
Hr生成する7ステムを共存させる。この/ステムには
、例えば、グルコースデヒPCIデナーゼによるグルコ
ースからのグルコン酸生成反応に於けるNADPのNA
DPHへの変換を利用するNADPH再生システム等r
好適に利用出来る。
As a coenzyme, to make NAJ)PHk essential, add NADPH' (required amount in advance or add NADP to the reaction system)
7 stems that generate Hr coexist. This/stem contains, for example, the NADP of NADP in the gluconic acid production reaction from glucose by glucose dehydrogenase PCI denase.
NADPH regeneration system, etc. that utilizes conversion to DPH
Can be used suitably.

反応温度は5〜70℃、好ましくは20〜40°C1反
応−は4〜10、好ましくは6〜8に調整すれば、本発
明の目的は十分に発揮される。
When the reaction temperature is adjusted to 5 to 70°C, preferably 20 to 40°C, the object of the present invention can be fully achieved by adjusting the reaction temperature to 4 to 10, preferably 6 to 8.

〔実施例〕〔Example〕

以下、実施例で本発明を具体的に説明する。例中、特に
断わらない限り俤は重量%である。
Hereinafter, the present invention will be specifically explained with reference to Examples. In the examples, unless otherwise specified, the weight is % by weight.

酵素単離例 グルコース5 重量1、コーンステイーフリカー5重量
%から成るP)16.0の培地5tti試験管に取シ、
スポロボロミセス・サルモニカラ−IF01038に一
接種して28℃で2日間撮とう培養を行ない種培養を得
た。
Enzyme Isolation Example Glucose 5 1 wt. P) 16.0 medium consisting of 5 wt.
A seed culture was obtained by inoculating Sporobolomyces salmonicolar IF01038 and culturing at 28°C for 2 days.

上記と同一組成の培地50011jt−2J容フラスコ
に取り、種培養5cjQ添加して28℃で4日間損とう
培養を行なった。次に上記フラスコ10本?合せて、5
1の培養液から遠心分離(2800G。
A culture medium having the same composition as above was placed in a 50011jt-2J volume flask, seed culture 5cjQ was added, and lesion culture was performed at 28°C for 4 days. Next, the 10 flasks mentioned above? In total, 5
Centrifugation (2800G) from the culture solution of 1.

20分間)で回収した培養菌体に0.01MIJン酸緩
衝液(pH7,4)で洗浄後、ダイノミル(ビーズ0.
25〜0.5 myxφ)で20分間処処理性ない、2
8000Gで20分間遠心分離してケン濁物質を除き、
粗酵素液を得た。このものに、硫安を加えて60〜80
飽和チの画分子遠心分離(28,000G x 30分
)で回収し、o、o I M酸緩衝液(FJ(7,0’
)で20時間透析した。次に、DEAR−セファセルカ
ラムクロマトグラフィ(1,6φ×60儂)に吸着させ
、上記緩衝液で洗浄後、塩化ナトリウム0から0.6 
M ’に含む同緩衝液による直線グラジェント溶出を行
なった。活性を示した両分を集め限外ろ過機(アミコン
社、YM 10 ’)で濃縮後、デルろ過カラム(セフ
ァデックス、G−100,2,0φx90cvL)に供
給し、0.1MのNaCj  k含む上記緩衝液でクロ
マトグラフを行ない、活性を示した両分を集め、上記と
同様の方法でデルろ過りロマトグラフィ?行ない精製酵
素液を調製した。このものは電気泳動的に単一パy H
e f示した。
After washing the cultured bacteria collected after 20 minutes with 0.01 MIJ acid buffer (pH 7.4), Dynomil (beads with 0.
25 to 0.5 myxφ) for 20 minutes, 2
Centrifuge at 8000G for 20 minutes to remove suspended matter.
A crude enzyme solution was obtained. Add ammonium sulfate to this and add 60 to 80
The saturated fraction was collected by molecular centrifugation (28,000 G
) for 20 hours. Next, it was adsorbed on DEAR-Sephacel column chromatography (1.6φ x 60mm), and after washing with the above buffer, sodium chloride 0 to 0.6
Linear gradient elution was performed using the same buffer contained in M'. Both fractions that showed activity were collected and concentrated using an ultrafilter (Amicon, YM 10'), then supplied to a Dell filtration column (Sephadex, G-100, 2,0φ x 90cvL) containing 0.1M NaCjk. Perform chromatography using the above buffer, collect the two fractions that showed activity, and perform chromatography using Delfiltration in the same manner as above. A purified enzyme solution was prepared. This is electrophoretically a single pyH
ef showed.

実施例1 酵素単離例で得た精製酵素を使用し第6表の条件下、還
元反応を行なつt0反応終了液を酢酸エチル200dで
2回抽出した後、Na8S04テ脱水後酢酸エチルを減
圧除去した。残った無色透明の液体7 NMR分析し次
結果、次のとおシであつ九のでγ−クロルーβ−ハイド
ロキシ酪酸エチルであること?確認し几。
Example 1 Using the purified enzyme obtained in Enzyme Isolation Example, a reduction reaction was carried out under the conditions shown in Table 6. The t0 reaction completed solution was extracted twice with 200 d of ethyl acetate, and after dehydration with Na8S04, the ethyl acetate was removed under reduced pressure. Removed. The remaining colorless and transparent liquid 7 was analyzed by NMR and the following results showed that it was ethyl γ-chloro-β-hydroxybutyrate. Please confirm.

NMR(CDCj3)δ(pp−) :1−25 (3
H、tr 、  CH3CH2−)0)T    0 3−6 (2Hs d、C1−C’H2・CH−)CH 3,22(IE(、br 、 −OH)2.62 (2
E(、a 、−cH−cHL−coaR)CH またGQ分析にエリ純度98.2チで収量は0.474
 g(収率92チ)であった。このものはMTPAエス
テルのHPLC分析よシ光学純度974eeの(R)一
体であった。
NMR (CDCj3) δ (pp-): 1-25 (3
H, tr, CH3CH2-)0)T03-6 (2Hs d, C1-C'H2・CH-)CH3,22(IE(,br, -OH)2.62 (2
E(,a,-cH-cHL-coaR)CH Also, the yield was 0.474 with an Eri purity of 98.2% for GQ analysis.
g (yield: 92 g). This product had an optical purity of 974ee according to HPLC analysis of MTPA ester.

第6表中の酵素活性Uは次による。The enzyme activity U in Table 6 is as follows.

γ−クロルアセト酢酸エチルエステルから1分間に1μ
モルのγ−クロルーβ−ハイドロ午シ酪酸エチルエステ
ルを生成する能力t1単位(U)とする。
1μ per minute from γ-chloroacetoacetic acid ethyl ester
The ability to produce moles of γ-chloroβ-hydrobutyric acid ethyl ester is defined as t1 units (U).

第6表 実施例2 第7表に示すNADPHの再生システムr含む条件下、
第8表のr−fl換アセト酢酸エステルr基質トシテ反
応を開始し、Q、5 N−NaOHでpJ4 k 6.
5に維持しつつ20時間反応した。反応終了後実施例1
と同様に操作し、生成物?分析し穴。NMR分析結果、
生成物?確認した。を九、収量(率)、光学純度等を第
8表に示す。
Table 6 Example 2 Conditions including the NADPH regeneration system shown in Table 7.
Start the reaction with the r-fl converted acetoacetate r substrate shown in Table 8, pJ4 k with Q, 5 N-NaOH 6.
The reaction was carried out for 20 hours while maintaining the temperature at 5. Example 1 after completion of reaction
and the product as well? Analyze the hole. NMR analysis results,
Product? confirmed. The yield (rate), optical purity, etc. are shown in Table 8.

第7表 γ−クロルーβ−ハイドロ中ン酪酸メチルNMR(CD
Cl2)δ(pptn) :6−6 (3H1s 、 
CH3−) 4.20 (IH,−CHzCH−CHz )OH OH 5−22(IH、br 、 −OH) OH γ−クロルーβ−ハイPロキク酪酸エチル実施例1に同
じ。
Table 7 γ-chloro-β-hydrobutyrate methyl NMR (CD
Cl2) δ(pptn): 6-6 (3H1s,
CH3-) 4.20 (IH, -CHzCH-CHz)OH OH 5-22 (IH, br, -OH) OH γ-chloro-β-hyP ethyl chloride butyrate Same as Example 1.

γ−クロルーβ−ハイドロキシ酪酸オクチルNMR(C
r)C13)δ(ppm) :o−ss (3H% t
rs CH3−(CHz)n−)1.28 (10H、
s 、 −(CH2)5− )OH 3−22(IH、br 、 −0H) OHO γ−ゾロモーβ−ハイドロ争シ酪酸エチルγ−フルオロ
−β−Il いずれもクロル体エチルエステルにほぼ同1γ−アジ?
−β−ハイPロキシ酪酸エチルNMR(cDCj3)δ
(ppm) :1−25 (3H% ”r % CH3
CHz−)OH0 3,22(IH、br 、 −OH) 〔発明の効果〕
γ-chloro-octyl β-hydroxybutyrate NMR (C
r) C13) δ (ppm): o-ss (3H% t
rs CH3-(CHz)n-)1.28 (10H,
s, -(CH2)5-)OH 3-22(IH, br, -0H) OHO γ-Zolomoβ-hydrobutyric acid ethyl γ-fluoro-β-Il Both are almost identical to chloride ethyl ester 1γ- Horse mackerel?
-β-hyP ethyl butyrate NMR (cDCj3) δ
(ppm): 1-25 (3H%"r% CH3
CHz-)OH0 3,22 (IH, br, -OH) [Effects of the invention]

Claims (1)

【特許請求の範囲】[Claims] γ−置換アセト酢酸エステルにスポロボロマイセス属由
来の還元型ニコチンアミド・アデニン・ジヌクレオチド
・リン酸依存性還元酵素を作用させる事を特徴とする(
R)−γ−置換−β−ハイドロキシ酪酸エステルの製造
法。
It is characterized by the action of a reduced nicotinamide adenine dinucleotide phosphate-dependent reductase derived from the genus Sporobolomyces on γ-substituted acetoacetate (
R) Method for producing -γ-substituted-β-hydroxybutyric acid ester.
JP62142916A 1987-06-08 1987-06-08 Method for producing (R) -r-substituted-β-hydroxybutyric acid ester Expired - Fee Related JP2566960B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62142916A JP2566960B2 (en) 1987-06-08 1987-06-08 Method for producing (R) -r-substituted-β-hydroxybutyric acid ester

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62142916A JP2566960B2 (en) 1987-06-08 1987-06-08 Method for producing (R) -r-substituted-β-hydroxybutyric acid ester

Publications (2)

Publication Number Publication Date
JPS63304991A true JPS63304991A (en) 1988-12-13
JP2566960B2 JP2566960B2 (en) 1996-12-25

Family

ID=15326606

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62142916A Expired - Fee Related JP2566960B2 (en) 1987-06-08 1987-06-08 Method for producing (R) -r-substituted-β-hydroxybutyric acid ester

Country Status (1)

Country Link
JP (1) JP2566960B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998035025A1 (en) * 1997-02-07 1998-08-13 Kaneka Corporation Novel carbonyl reductase, gene that encodes the same, and method of utilizing these

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004266100A1 (en) 2003-08-11 2005-03-03 Codexis, Inc. Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives and vicinal cyano, hydroxy substituted carboxylic acid esters

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998035025A1 (en) * 1997-02-07 1998-08-13 Kaneka Corporation Novel carbonyl reductase, gene that encodes the same, and method of utilizing these
US6218156B1 (en) 1997-02-07 2001-04-17 Kaneka Corporation Gene encoding carbonyl reductase, and methods for its use
US6448052B2 (en) 1997-02-07 2002-09-10 Kaneka Corporation Carbonyl reductase enzyme and methods for its use

Also Published As

Publication number Publication date
JP2566960B2 (en) 1996-12-25

Similar Documents

Publication Publication Date Title
Peters et al. A novel NADH-dependent carbonyl reductase with an extremely broad substrate range from Candida parapsilosis: purification and characterization
KR880001944B1 (en) 2,5-diketo-d-gluconic acid reductase
JPS63304991A (en) Production of (r)-gamma-substituted-beta-hydroxybutyric ester
US5296358A (en) Process for the enzymatic preparation of cephalosporanic derivatives using a D-amino acid oxidase from Rhodotorula glutinis NCIMB 40412
JP3919918B2 (en) Process for producing optically active 2-halo-1- (substituted phenyl) ethanol
US6214610B1 (en) Process for the preparation of optically active N-benzyl-3-pyrrolidinol
JPH02283295A (en) Production of optically active (r)-(-)-3-halo-1,2-propanediol
EP1550730B1 (en) Method for producing optically active 3-chloro-2-methyl-1,2-propanediol taking advantage of microorganism
DE60318297T2 (en) enone reductase
JPS58201985A (en) Production of glucose dehydrogenase
JP2538597B2 (en) Novel ring enzyme
US5610045A (en) Producing a high content of acetate kinase using bacillus stearothermophilus
JPH09224660A (en) Aldehyde dehydrogenase
DE60038513T2 (en) Levodion reductase
JPH04341195A (en) Production of optically active mandelic acid
JPH10150998A (en) Production of n-benzyl-3-pyrrolidinol
JP2750017B2 (en) Novel enzyme, method for producing the same, and method for producing optically active (R) -2-hydroxy-4-phenylbutyric acid
JP3747640B2 (en) Process for producing optically active 1,2-diol cyclic carbonate
JPH04152895A (en) Production of optically active 1,3-butanediol
JP3893721B2 (en) Method for producing optically active compound
JP3192835B2 (en) Method for producing (S) -1,3-butanediol
JP2801694B2 (en) New enzyme
Fischer Capacity of the yeast Trigonopsis variabilis (DSM 70714) for the enantioselective reduction of organosilicon compounds
JPH0494689A (en) Production of optically active (s)-(+)-3-halo-1,2-propanediol
JP2828720B2 (en) Method for producing optically active 1,3-butanediol

Legal Events

Date Code Title Description
S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees